TSVT (2seventy Bio) Quick Liquidity
The 2seventy bio, Inc. (TSVT) price chart illustrates the asset's dynamics, with its current value standing at 4.92. The company is currently pivoting its operations toward the development of ophthalmology software alongside a major partner. Previously, the business relied on the sale of advanced myeloma treatments, where the Abecma product provided exceptional pricing power. Revenue is generated through the sale of innovative cell therapies and partner grants.
2seventybio.com (TSVT) - metric breakdowns and financial figures
High laboratory utilization at 2seventy bio, Inc. (TSVT) requires a constant influx of working capital to modernize cryogenic systems. The current value of 4.92 reflects the company's ability to settle short-term debts using cash and accounts receivable, completely ignoring slow-moving inventories. Analyzing the liquidity ratio excluding inventories allows for an assessment of the business's real solvency without considering stock remnants. This metric determines the asset's resilience to sudden market shocks.